Tg Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tg Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $8.7M | 489k | 17.79 |
| 2023-09-30 | $1.2M | 146k | 8.36 |
| 2023-03-31 | $3.5M | 231k | 15.04 |
| 2022-06-30 | $8.9M | 2.1M | 4.25 |
| 2022-03-31 | $2.4M | 254k | 9.51 |
| 2021-12-31 | $3.1M | 162k | 19.00 |
| 2021-06-30 | $5.9M | 153k | 38.79 |
| 2021-03-31 | $7.5M | 156k | 48.20 |
| 2018-12-31 | $643k | 157k | 4.10 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management